Operating activities |
Net income |
56.32M |
Adjustments to reconcile net income to net cash provided by operating activities |
Depreciation, depletion and amortization |
77.27M |
Amortization of debt issuance costs |
1.3M |
Accretion of asset retirement obligation |
4.14M |
Accretion of convertible debt discount |
5.31M |
Loss on early extinguishment of debt |
0 |
Share-based Compensation |
7.47M |
Gain on sale of fixed assets and investments |
-683K |
Change in fair value of derivative instruments |
-14.77M |
Deferred income tax expense |
7.84M |
Other |
1.99M |
Changes in operating assets and liabilities |
Trade accounts receivable |
5.61M |
Notes and other receivables |
909K |
Inventories |
-13.07M |
Prepaid expenses and other current assets |
-31.65M |
Other assets |
1.59M |
Trade accounts payable |
-23.59M |
Accrued expenses and other current liabilities |
-30.58M |
Workers’ compensation obligations |
504K |
Postretirement medical obligations |
2.93M |
Asset retirement obligation |
-2.26M |
Other liabilities |
980K |
Net cash provided by operating activities |
57.58M |
Investing activities |
Capital expenditures |
-46.11M |
Proceeds from disposition of property, plant, and equipment |
387K |
Proceeds from sale of investment in coal terminal |
0 |
Investment in Dominion Terminal Facility |
0 |
Purchase of acquired companies |
-1.75M |
Other |
-75K |
Net cash used in investing activities |
-47.55M |
Financing activities |
Repayments of note payable |
-10.89M |
Proceeds from issuance of convertible debt |
0 |
Repayments on long-term debt |
-232K |
Proceeds from Issuance of Common Stock |
0 |
Debt issuance costs |
-5.28M |
Premium payment on early extinguishment of debt |
0 |
Tax benefit from share-based compensation |
0 |
Common stock repurchases |
-2.03M |
Proceeds from exercise of stock options |
230K |
Other |
-651K |
Net cash used in financing activities |
-18.85M |
Net increase (decrease) in cash and cash equivalents |
-8.82M |
Cash and cash equivalents at beginning of year |
676.19M |
Cash and cash equivalents at end of period |
667.37M |